MILESON GLENNA 4
4 · Athira Pharma, Inc. · Filed Apr 12, 2022
Insider Transaction Report
Form 4
MILESON GLENNA
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-04-11−3,000→ 167,000 totalExercise: $10.64Exp: 2032-01-17→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2022-04-11$10.64/sh+3,000$31,920→ 100,060 total
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.